We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease. A Cross Sectional Study in Norway.

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01524328
First Posted: February 1, 2012
Last Update Posted: February 1, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Oslo University Hospital
  Purpose
The purpose of this study is to investigate the proportion of use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD). In addition, the reason for, and satisfaction with use of CAM.

Condition
Inflammatory Bowel Diseases

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease. A Cross Sectional Study in Norway.

Further study details as provided by Oslo University Hospital:

Enrollment: 460
Study Start Date: October 2009
Study Completion Date: June 2011
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult patients with (>18 years) a verified diagnosis of Crohn`s disease or ulcerative colitis attending an outpatient clinic in a Norwegian hospital.
Criteria

Inclusion Criteria:

  • Patients >18 years and with verified diagnosis of Crohn`s disease or ulcerative colitis attending an outpatient clinic in a Norwegian hospital.

Exclusion Criteria:

  • Patients <18 years.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01524328


Locations
Norway
Oslo university hospital
Oslo, Norway, 0424
Sponsors and Collaborators
Oslo University Hospital
Investigators
Principal Investigator: Bjorn Moum, professor Oslo University Hospital
  More Information

Responsible Party: Oslo University Hospital
ClinicalTrials.gov Identifier: NCT01524328     History of Changes
Other Study ID Numbers: 2010/1683/
First Submitted: January 30, 2012
First Posted: February 1, 2012
Last Update Posted: February 1, 2012
Last Verified: January 2012

Keywords provided by Oslo University Hospital:
Complementary and alternative medicine
HRQoL, Inflammatory bowel disease

Additional relevant MeSH terms:
Intestinal Diseases
Inflammatory Bowel Diseases
Gastrointestinal Diseases
Digestive System Diseases
Gastroenteritis